Cabotegravir (original) (raw)
- Cabotegravir, sold under the brand name Vocabria among others, is a antiretroviral medication used for the treatment of HIV/AIDS. It is available in the form of tablets and as an intramuscular injection, as well as in an injectable combination with rilpivirine under the brand name Cabenuva. It is an integrase inhibitor with a carbamoyl pyridone structure similar to that of dolutegravir. In December 2021, the U.S. Food and Drug Administration approved cabotegravir for pre-exposure prophylaxis (PrEP) in at-risk people under the brand name Apretude. (en)
- Le cabotégravir est une molécule de type inhibiteur de l'intégrase du VIH, avec une demi-vie longue, en cours de test depuis le début des années 2010 comme traitement de ce dernier. il présente une structure carbamoyl pyrimidone lié via un amide à un substituant difluorobenzène similaire à celle du dolutégravir. (fr)
- 카보테그라비르(Cabotegravir, 상품명 보카브리아)는 성인 에이즈 치료에 사용되는 약물이다. 이것은 카베누바라는 상품명으로, 주사제로써 릴피비린과 병용투여가 가능할뿐만 아니라, 근육 주사제 및 정제로도 사용할 수 있다. 한 달에 한 번 또는 두 달에 한 번 투여할 수 있다. Carbamoyl pyridone 구조인 유사한 돌루테그라비어(dolutegravir)와 작용기전이 유사한 인테그레이즈 억제제이다. (ko)
- Cabotegravir é um fármaco que está sendo testado para o tratamento de infecção pelo HIV, desenvolvida pelos laboratórios .Pentence a classe dos inibidores de integrase. Teria como vantagem ser uma droga de longa duração, que combinada com outros antirretrovirais, pretende ser injetável e evitar os comprimidos diários de tratamento da Aids. (pt)
- Каботегравир (торговая марка Vocabria) — лекарство, используемое для лечения ВИЧ/СПИДа у взрослых. Он доступен в форме таблеток и в виде внутримышечной инъекции, а также в виде инъекционной комбинации с рилпивирином под торговой маркой Cabenuva. Лекарственные формы для инъекций применяются один раз в месяц или один раз в два месяца . Это ингибитор интегразы со структурой карбамоилпиридона, аналогичной структуре долутегравира. (ru)
- Apretude, Cabenuva, Vocabria (en)
- 1051375-10-0
- 1051375-13-3
- 172944
- 172948
- 2403238
- 3137330
- DB11751
- DBSALT002064
- 3L12PT535M
- HMH0132Z1Q
- D10548
- D10549
- a621010
- 54713659
- 39635641 (xsd:integer)
- 20947 (xsd:nonNegativeInteger)
- 1123269367 (xsd:integer)
- dbr:Cabotegravir/rilpivirine
- dbr:Carbamazepine
- dbr:Enzyme_inducer
- dbr:Nanoparticle
- dbr:Blood_plasma
- dbr:Depressive_disorder
- dbr:Aqueous_solution
- dbr:Rifampicin
- dbr:Rifapentine
- dbr:Rilpivirine
- dbr:DNA
- dbr:Integrase
- dbr:Integrase_inhibitor
- dbr:International_nonproprietary_name
- dbr:Intramuscular_injection
- dbc:Fluoroarenes
- dbc:Heterocyclic_compounds_with_3_rings
- dbr:Genome
- dbr:Oral_administration
- dbr:Emtricitabine/tenofovir
- dbc:Oxazolidines
- dbr:Committee_for_Medicinal_Products_for_Human_Use
- dbr:Zimbabwe
- dbr:Pain
- dbr:Poor_metabolizer
- dbr:Suspension_(chemistry)
- dbr:2-Pyridone
- dbr:Transgender
- dbr:HPTN_083
- dbr:Pre-exposure_prophylaxis
- dbr:Acid_dissociation_constant
- dbr:Africa
- dbc:4-Pyridones
- dbc:Carboxamides
- dbr:Edema
- dbr:European_Medicines_Agency
- dbr:Fever
- dbr:Food_and_Drug_Administration
- dbr:Oxcarbazepine
- dbr:PH
- dbr:Glucuronidation
- dbr:Glucuronide
- dbr:Viral_replication
- dbr:HIV/AIDS
- dbr:Headache
- dbr:Asymmetric_carbon
- dbc:Breakthrough_therapy
- dbr:Bile
- dbr:Biological_half-life
- dbr:Dolutegravir
- dbc:Integrase_inhibitors
- dbr:CYP3A4
- dbr:Phenobarbital
- dbr:Phenytoin
- dbr:Sodium
- dbr:Cisgender
- dbr:Antiretroviral
- dbr:Antiretroviral_medication
- dbr:Insomnia
- dbr:Lumen_(anatomy)
- dbr:UGT1A1
- dbr:United_States_Adopted_Name
- dbr:Carboxamide
- dbr:Viral_load
- dbr:UGT1A9
- dbr:Rashes
- dbr:Intramuscular
- dbr:Undetectable
- dbr:Integrase_strand_transfer_inhibitor
- dbr:Non-nucleoside_reverse_transcriptase_inhibitor
- dbr:Plasma_protein
- dbr:File:Cabotegravir_glucuronide.svg
- J05 (en)
- AJ04 (en)
- 19 (xsd:integer)
- 1051375 (xsd:integer)
- 172944 (xsd:integer)
- 172948 (xsd:integer)
- 2403238 (xsd:integer)
- 3137330 (xsd:integer)
- 30829503 (xsd:integer)
- 32702138 (xsd:integer)
- Cabotegravir (en)
- DB11751 (en)
- DBSALT002064 (en)
- 147600.0
- injection: 5.6–11.5 weeks (en)
- 47 (xsd:integer)
- 2 (xsd:integer)
- 17 (xsd:integer)
- Cabotegravir ball-and-stick model.png (en)
- as salt (en)
- N--6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolopyridopyrazine-8-carboxamide (en)
- D10548 (en)
- D10549 (en)
- S4 (en)
- Rx-only (en)
- Rx-only (en)
- Rx-only (en)
- yes (en)
- a621010 (en)
- 3 (xsd:integer)
- 5 (xsd:integer)
- B1 (en)
- >99% (en)
- 46215800 (xsd:integer)
- 54713659 (xsd:integer)
- C[C@H]1CO[C@H]2N1Cc3cO (en)
- [Na+].C[C@H]1CO[C@@H]2CN3C=CCC=C3CN12 (en)
- 1 (xsd:integer)
- AEZBWGMXBKPGFP-KIUAEZIZSA-M (en)
- WCWSTNLSLKSJPK-LKFCYVNXSA-N (en)
- S/GSK1265744, GSK744 (en)
- Apretude, Cabenuva, Vocabria (en)
- 3 (xsd:integer)
- HMH0132Z1Q (en)
- dbt:Cite_web
- dbt:Convert
- dbt:Fact
- dbt:Infobox_drug
- dbt:Portal_bar
- dbt:Reflist
- dbt:Short_description
- dbt:Use_British_English
- dbt:Use_dmy_dates
- dbt:Cascite
- dbt:Ebicite
- dbt:Fdacite
- dbt:Drugs.com
- dbt:Antiretroviral_drug
- dbc:Fluoroarenes
- dbc:Heterocyclic_compounds_with_3_rings
- dbc:Oxazolidines
- dbc:4-Pyridones
- dbc:Carboxamides
- dbc:Breakthrough_therapy
- dbc:Integrase_inhibitors
- owl:Thing
- dul:ChemicalObject
- dbo:ChemicalSubstance
- wikidata:Q8386
- yago:Inhibitor114724436
- yago:Matter100020827
- yago:PhysicalEntity100001930
- yago:WikicatIntegraseInhibitors
- dbo:Drug
- yago:Substance100020090
- Cabotegravir, sold under the brand name Vocabria among others, is a antiretroviral medication used for the treatment of HIV/AIDS. It is available in the form of tablets and as an intramuscular injection, as well as in an injectable combination with rilpivirine under the brand name Cabenuva. It is an integrase inhibitor with a carbamoyl pyridone structure similar to that of dolutegravir. In December 2021, the U.S. Food and Drug Administration approved cabotegravir for pre-exposure prophylaxis (PrEP) in at-risk people under the brand name Apretude. (en)
- Le cabotégravir est une molécule de type inhibiteur de l'intégrase du VIH, avec une demi-vie longue, en cours de test depuis le début des années 2010 comme traitement de ce dernier. il présente une structure carbamoyl pyrimidone lié via un amide à un substituant difluorobenzène similaire à celle du dolutégravir. (fr)
- 카보테그라비르(Cabotegravir, 상품명 보카브리아)는 성인 에이즈 치료에 사용되는 약물이다. 이것은 카베누바라는 상품명으로, 주사제로써 릴피비린과 병용투여가 가능할뿐만 아니라, 근육 주사제 및 정제로도 사용할 수 있다. 한 달에 한 번 또는 두 달에 한 번 투여할 수 있다. Carbamoyl pyridone 구조인 유사한 돌루테그라비어(dolutegravir)와 작용기전이 유사한 인테그레이즈 억제제이다. (ko)
- Cabotegravir é um fármaco que está sendo testado para o tratamento de infecção pelo HIV, desenvolvida pelos laboratórios .Pentence a classe dos inibidores de integrase. Teria como vantagem ser uma droga de longa duração, que combinada com outros antirretrovirais, pretende ser injetável e evitar os comprimidos diários de tratamento da Aids. (pt)
- Каботегравир (торговая марка Vocabria) — лекарство, используемое для лечения ВИЧ/СПИДа у взрослых. Он доступен в форме таблеток и в виде внутримышечной инъекции, а также в виде инъекционной комбинации с рилпивирином под торговой маркой Cabenuva. Лекарственные формы для инъекций применяются один раз в месяц или один раз в два месяца . Это ингибитор интегразы со структурой карбамоилпиридона, аналогичной структуре долутегравира. (ru)
- Cabotegravir (en)
- Cabotégravir (fr)
- 카보테그라비르 (ko)
- Cabotegravir (pt)
- Каботегравир (ru)
- freebase:Cabotegravir
- yago-res:Cabotegravir
- wikidata:Cabotegravir
- dbpedia-fa:Cabotegravir
- dbpedia-fr:Cabotegravir
- dbpedia-he:Cabotegravir
- dbpedia-ko:Cabotegravir
- dbpedia-pt:Cabotegravir
- dbpedia-ru:Cabotegravir
- dbpedia-sh:Cabotegravir
- dbpedia-sr:Cabotegravir
- https://global.dbpedia.org/id/Xrqk
- wiki-commons:Special:FilePath/Cabotegravir_(GSK744).svg
- wiki-commons:Special:FilePath/Cabotegravir_ball-and-stick_model.png
- wiki-commons:Special:FilePath/Cabotegravir_glucuronide.svg
is dbo:wikiPageRedirects of
- dbr:GSK744
- dbr:C19H17F2N3O5
- dbr:Apretude
- dbr:Vocabria
- dbr:S/GSK1265744
- dbr:GSK-1265744
- dbr:GSK1265744
- dbr:GSK_1265744
- dbr:Cabotegravir_sodium
is dbo:wikiPageWikiLink of
- dbr:Cabotegravir/rilpivirine
- dbr:List_of_antiretroviral_fixed-dose_combinations
- dbr:Treatment_as_prevention
- dbr:2020_in_Botswana
- dbr:David_Ho
- dbr:Rilpivirine
- dbr:Charles_Flexner
- dbr:ViiV_Healthcare
- dbr:Integrase_inhibitor
- dbr:GSK744
- dbr:Nanomedicine
- dbr:C19H17F2N3O5
- dbr:HIV_Prevention_Trials_Network
- dbr:HIV_vaccine_development
- dbr:HPTN_083
- dbr:Pre-exposure_prophylaxis
- dbr:Four_Thieves_Vinegar_Collective
- dbr:HIV/AIDS
- dbr:ATC_code_J05
- dbr:Apretude
- dbr:Management_of_HIV/AIDS
- dbr:List_of_drugs:_C–Ca
- dbr:Vocabria
- dbr:S/GSK1265744
- dbr:GSK-1265744
- dbr:GSK1265744
- dbr:GSK_1265744
- dbr:Cabotegravir_sodium
is foaf:primaryTopic of